Myasthenia Gravis Disease Market Size, Share, and Competitive Landscape: Industry Insights
Valued at USD 2.60 billion in 2024, the myasthenia gravis disease market is projected to reach USD 2.83 billion in 2025 and USD 6.19 billion by 2034, growing at a CAGR of 9.1% during the forecast period 2025–2034. Growth is driven by the increasing global prevalence of myasthenia gravis, advancements in diagnostic techniques, and the development of innovative therapies. Key players...
0 Комментарии 0 Поделились 86 Просмотры 0 предпросмотр
SocioMint https://sociomint.com